BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36330850)

  • 1. A qualitative evaluation of the revised amyotrophic lateral sclerosis functional rating scale (ALSFRS-R) by the patient community: a web-based cross-sectional survey.
    Boyce D; Robinson M; Cedarbaum JM; Shank LM; McDermott CJ; van Eijk RPA
    Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):272-280. PubMed ID: 36330850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS).
    Fournier CN; Bedlack R; Quinn C; Russell J; Beckwith D; Kaminski KH; Tyor W; Hertzberg V; James V; Polak M; Glass JD
    JAMA Neurol; 2020 Apr; 77(4):480-488. PubMed ID: 31886839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal comparison of the self-entry Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-RSE) and Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) as outcome measures in people with amyotrophic lateral sclerosis.
    Johnson SA; Burke KM; Scheier ZA; Keegan MA; Clark AP; Chan J; Fournier CN; Berry JD
    Muscle Nerve; 2022 Oct; 66(4):495-502. PubMed ID: 35904151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the Measurement Properties of the Self-Administered Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R): A Rasch Analysis.
    Mehdipour A; Teshler L; Dal Bello-Haas V; Richardson J; Beauchamp M; Turnbull J; Chum M; Johnston W; O'Connell C; Luth W; Kuspinar A
    Phys Ther; 2023 Nov; 103(11):. PubMed ID: 37581600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and specificity of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised to detect dysarthria in individuals with amyotrophic lateral sclerosis.
    Donohue C; Chapin JL; Anderson A; DiBiase L; Gray LT; Wymer JP; Plowman EK
    Muscle Nerve; 2023 Sep; 68(3):296-302. PubMed ID: 37345346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the measurement properties of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R): deriving a valid measurement total for the calculation of change.
    Young CA; Chaouch A; Mcdermott CJ; Al-Chalabi A; Chhetri SK; Talbot K; Malaspina A; Mills R; Tennant A
    Amyotroph Lateral Scler Frontotemporal Degener; 2024 May; 25(3-4):400-409. PubMed ID: 38426231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of a telephone survey system for patients with amyotrophic lateral sclerosis using the ALSFRS-R (Japanese version) and application of this system in a longitudinal multicenter study].
    Atsuta N; Watanabe H; Ito M; Nakamura R; Senda J; Kato S; Sobue G
    Brain Nerve; 2011 May; 63(5):491-6. PubMed ID: 21515929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refining items for a preference-based, amyotrophic lateral sclerosis specific, health-related quality of life scale.
    Van Damme J; Kuspinar A; Johnston W; O'Connell C; Turnbull J; Chum M; Strachan P; Luth W; McCullum S; Peters N; MacDermid J; Dal Bello-Haas V
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Nov; 23(7-8):508-516. PubMed ID: 35147072
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of bulbar function in amyotrophic lateral sclerosis: validation of a self-report scale (Center for Neurologic Study Bulbar Function Scale).
    Smith RA; Macklin EA; Myers KJ; Pattee GL; Goslin KL; Meekins GD; Green JR; Shefner JM; Pioro EP
    Eur J Neurol; 2018 Jul; 25(7):907-e66. PubMed ID: 29577526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) Japanese version].
    Ohashi Y; Tashiro K; Itoyama Y; Nakano I; Sobue G; Nakamura S; Sumino S; Yanagisawa N
    No To Shinkei; 2001 Apr; 53(4):346-55. PubMed ID: 11360474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
    Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-Minute Walk Test as a Measure of Walking Capacity in Ambulatory Individuals With Amyotrophic Lateral Sclerosis.
    Sanjak M; Langford V; Holsten S; Rozario N; Patterson CGM; Bravver E; Bockenek WL; Brooks BR
    Arch Phys Med Rehabil; 2017 Nov; 98(11):2301-2307. PubMed ID: 28465220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Item response theory analysis of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised in the Pooled Resource Open-Access ALS Clinical Trials Database.
    Bacci ED; Staniewska D; Coyne KS; Boyer S; White LA; Zach N; Cedarbaum JM;
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(3-4):157-67. PubMed ID: 26473473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the factorial validity and reliability of the ALSFRS-R: a revision of its measurement model.
    Bakker LA; Schröder CD; van Es MA; Westers P; Visser-Meily JMA; van den Berg LH
    J Neurol; 2017 Jul; 264(7):1413-1420. PubMed ID: 28608303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The frequency of ALSFRS-R reversals and plateaus in patients with limb-onset amyotrophic lateral sclerosis: a cohort study.
    Hu N; Shen D; Yang X; Cui L; Liu M
    Acta Neurol Belg; 2022 Dec; 122(6):1567-1573. PubMed ID: 35034333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.
    ;
    Lancet Neurol; 2017 Jul; 16(7):505-512. PubMed ID: 28522181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALSFRS-R-SE: an adapted, annotated, and self-explanatory version of the revised amyotrophic lateral sclerosis functional rating scale.
    Maier A; Boentert M; Reilich P; Witzel S; Petri S; Großkreutz J; Metelmann M; Lingor P; Cordts I; Dorst J; Zeller D; Günther R; Hagenacker T; Grehl T; Spittel S; Schuster J; Ludolph A; Meyer T;
    Neurol Res Pract; 2022 Dec; 4(1):60. PubMed ID: 36522775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slowing the loss of physical function in amyotrophic lateral sclerosis with edaravone: Post hoc analysis of ALSFRS-R item scores in pivotal study MCI186-19.
    Brooks BR; Pioro EP; Katz J; Takahashi F; Takei K; Zhang J; Apple S
    Muscle Nerve; 2022 Feb; 65(2):180-186. PubMed ID: 34816454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility of the amyotrophic lateral sclerosis Functional Rating Scale-Revised to detect pharyngeal dysphagia in individuals with amyotrophic lateral sclerosis.
    Chapin JL; Gray LT; Vasilopoulos T; Anderson A; DiBiase L; York JD; Robison R; Wymer J; Plowman EK
    PLoS One; 2020; 15(8):e0236804. PubMed ID: 32790801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of the ALSFRS-R for Utilization in Individuals Not Using Noninvasive Ventilation.
    Vlok L; Rossouw L; Henning F
    Respir Care; 2022 May; 67(5):553-561. PubMed ID: 35473846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.